PHOENIX HEALTH GROUP
PHOENIX CIRENCESTER, 9 CHESTERTON LANE, CIRENCESTER
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 16 | 17 | 94.1% | |
| HF 4 | 2011 | 17 | 21 | 81.0% | |
| HF 4 | 2012 | 19 | 23 | 82.6% | |
| HF 4 | 2013 | 18 | 19 | 94.7% | |
| HF004 | 2014 | 17 | 17 | 100.0% | |
| HF004 | 2015 | 17 | 17 | 100.0% | |
| HF004 | 2016 | 16 | 17 | 94.1% | |
| HF004 | 2017 | 12 | 12 | 100.0% | |
| HF004 | 2018 | 12 | 12 | 100.0% | |
| HF004 | 2019 | 22 | 23 | 95.7% | |
| HF004 | 2020 | 40 | 46 | 87.0% | |
| HF006 | 2021 | 41 | 52 | 78.8% | |
| HF006 | 2022 | 48 | 60 | 80.0% | |
| HF006 | 2023 | 49 | 50 | 98.0% |
